Trial Profile
Phase I Study Of Sunitinib In Combination With Oxaliplatin, L-Leucovorin, And 5-Fluorouracil In Patients With Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Pfizer
- 21 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 21 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2010 Planned end date changed from 1 Jan 2010 to 1 May 2010 as reported by ClinicalTrials.gov.